Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid

Recent studies suggest an important role of immunoglobulin E (IgE) as an alternative pathogenic pathway in the development of bullous pemphigoid (BP), as the most frequent subepidermal blistering disease of the skin Use of IgE targeted therapies, such as omalizumab, has been shown promising in recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyed Jafari, S. Morteza, Gadaldi, Karolina, Feldmeyer, Laurence, Yawalkar, Nikhil, Borradori, Luca, Schlapbach, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702353/
https://www.ncbi.nlm.nih.gov/pubmed/31474990
http://dx.doi.org/10.3389/fimmu.2019.01919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702353/
https://www.ncbi.nlm.nih.gov/pubmed/31474990
http://dx.doi.org/10.3389/fimmu.2019.01919

Ejemplares similares